Skip to main content

Table 12 Sensitivity analysis results for a time horizon of 2 year and no discount rate

From: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis

 

Costs, €

Additional costs versus Aptima, €

Aptima® HPV

11,809,879.39 €

Hybrid Capture® 2

393,371,446.36 €*

381,561,664.97 €

Cobas® 4800

14,611,150.11 €

2,891,270.72 €

  1. *Includes HPV tests and other diagnostic tests (cytology, colposcopy, and biopsy)
  2. Includes the cost of HPV genotyping after the first and subsequent Hybrid Capture® 2 tests